Veterinary user fee reauthorization draws praise from industry group
Washington - The Animal Health Institute (AHI) applauded Congress for its swift passage of the Animal Drug User Fee Amendments.
Washington
- The Animal Health Institute (AHI) applauded Congress for its swift passage of the Animal Drug User Fee Amendments.
H.R. 6432 reauthorizes industry user fees of $98 million over the next five years to support the animal drug review process at the Food and Drug Administration (FDA). The user-fee program was created in 2003 to help streamline drug approvals at FDA by setting performance goals and funding for the review of new animal drug applications.
AHI's President and CEO Alexander S. Mathews says, "This bill is important for pet owners and for all food consumers. It will help ensure a steady supply of new and innovative products used by veterinarians, pet owners and farmer and ranchers to maintain health animals. For pet owners, it means a continuing pipeline of new and innovative products to treat cancer, heart disease and other ailments in our pets."
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
